Dr. Christina Lamers
Assistentin / PostDoc

Christina Lamers

Philosophisch-Naturwissenschaftliche Fakultät

Departement Pharmazeutische Wissenschaften

Molekulare Pharmazie

Assistentin / PostDoc

Klingelbergstrasse 50
4056 Basel

Tel. +41 61 207 15 56

Curriculum Vitae

Christina Lamers graduated in pharmacy in 2008 at the Goethe-University of Frankfurt/Main, Germany. Her practical year she spent 6 month at Merz Consumer Care, Frankfurt/Main before she got licensed as pharmacist in 2009. She was PhD student from 2010-2014 in the group of Prof. Manfred Schubert-Zsilavecz at the Pharmaceutical Chemistry Department of Goethe-University Frankfurt/Main. In 2014 she defended her PhD thesis titles “Synthesis and characterization of fatty acid mimetics as ligands for nuclear receptors PPARs and FXR”. From 2015 – 2017 she worked as a post-doctoral fellow on phage display evolved bicyclic peptides in the lab of Prof. Christian Heinis at EPFL, Switzerland. During this postdoc she won a Marie-Curie individual fellowship. In November 2017 she joined the group of Prof. Daniel Ricklin as post-doctoral fellow at the Institute of Molecular Pharmacy at the University Basel.


Flesch, D., Cheung, S.-Y., Schmidt, J., Gabler, M., Heitel, P., Kramer, J., Kaiser, A., Hartmann, M., Lindner, M., Lüddens-Dämgen, K., Heering, J., Lamers, C., Lüddens, H., Wurglics, M., Proschak, E., Schubert-Zsilavecz, M. und Merk, D. (2017) «Nonacidic Farnesoid X Receptor Modulators», Journal of Medicinal Chemistry, 60(16), S. 7199-7205. doi: 10.1021/acs.jmedchem.7b00903.   edoc
Lamers, C., Merk, D., Gabler, M., Flesch, D., Kaiser, A. und Schubert-Zsilavecz, M. (2016) «SAR studies on FXR modulators led to the discovery of the first combined FXR antagonistic/TGR5 agonistic compound», Future medicinal chemistry, 8(2), S. 133-148. doi: 10.4155/fmc.15.178.   edoc
Blöcher, R., Lamers, C., Wittmann, S. K., Merk, D., Hartmann, M., Weizel, L., Diehl, O., Brüggerhoff, A., Boß, M., Kaiser, A., Schader, T., Göbel, T., Grundmann, M., Angioni, C., Heering, J., Geisslinger, G., Wurglics, M., Kostenis, E., Brüne, B., Steinhilber, D., Schubert-Zsilavecz, M., Kahnt, A. S. und Proschak, E. (2016) «N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators», Journal of medicinal chemistry, 59(1), S. 61-81. doi: 10.1021/acs.jmedchem.5b01239.   edoc